These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21964164)

  • 1. New hope for type 2 diabetics: targeting insulin resistance through the immune modulation of stem cells.
    Zhao Y; Jiang Z; Guo C
    Autoimmun Rev; 2011 Dec; 11(2):137-42. PubMed ID: 21964164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial.
    Zhao Y; Jiang Z; Zhao T; Ye M; Hu C; Zhou H; Yin Z; Chen Y; Zhang Y; Wang S; Shen J; Thaker H; Jain S; Li Y; Diao Y; Chen Y; Sun X; Fisk MB; Li H
    BMC Med; 2013 Jul; 11():160. PubMed ID: 23837842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cord blood stem cells and the journey to a cure for type 1 diabetes.
    Zhao Y; Mazzone T
    Autoimmun Rev; 2010 Dec; 10(2):103-7. PubMed ID: 20728583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
    Duan SZ; Usher MG; Mortensen RM
    Circ Res; 2008 Feb; 102(3):283-94. PubMed ID: 18276926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.
    Zhao Y; Lin B; Dingeldein M; Guo C; Hwang D; Holterman MJ
    Transl Res; 2010 May; 155(5):211-6. PubMed ID: 20403575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune modulation of blood-derived stem cell as a comprehensive tool for treating type 1 diabetes.
    Zhao Y; Hwang D; Guo C
    Discov Med; 2009 Dec; 8(43):219-22. PubMed ID: 20040273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers and immune-modulating therapies for type 2 diabetes.
    Brooks-Worrell B; Narla R; Palmer JP
    Trends Immunol; 2012 Nov; 33(11):546-53. PubMed ID: 22897868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The accelerator hypothesis and increasing incidence of type 1 diabetes.
    Fourlanos S; Harrison LC; Colman PG
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):321-5. PubMed ID: 18594271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in treating diabetes mellitus with adult stem cells].
    Zhang L; Teng C; An T
    Sheng Wu Gong Cheng Xue Bao; 2008 Feb; 24(2):177-82. PubMed ID: 18464596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria.
    Higgins SJ; Kain KC; Liles WC
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):803-19. PubMed ID: 21905788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune regulation of T lymphocyte by a newly characterized human umbilical cord blood stem cell.
    Zhao Y; Huang Z; Qi M; Lazzarini P; Mazzone T
    Immunol Lett; 2007 Jan; 108(1):78-87. PubMed ID: 17161871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes.
    Westwell-Roper C; Nackiewicz D; Dan M; Ehses JA
    Immunol Cell Biol; 2014 Apr; 92(4):314-23. PubMed ID: 24492799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and prevention.
    Giannoukakis N; Pietropaolo M; Trucco M
    Curr Opin Investig Drugs; 2002 May; 3(5):735-51. PubMed ID: 12090547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-cell preservation: a potential role for thiazolidinediones to improve clinical care in Type 2 diabetes.
    Leiter LA
    Diabet Med; 2005 Aug; 22(8):963-72. PubMed ID: 16026359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cells from umbilical cord blood.
    Sanchez-Ramos J
    Semin Reprod Med; 2006 Nov; 24(5):358-69. PubMed ID: 17123231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of human MAPCs for stem cell transplantation and cardiac regeneration after myocardial infarction in SCID mice.
    Dimomeletis I; Deindl E; Zaruba M; Groebner M; Zahler S; Laslo SM; David R; Kostin S; Deutsch MA; Assmann G; Mueller-Hoecker J; Feuring-Buske M; Franz WM
    Exp Hematol; 2010 Nov; 38(11):1105-14. PubMed ID: 20621157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cord blood-derived multipotent stem cells (CB-SCs) treated with all-trans-retinoic acid (ATRA) give rise to dopamine neurons.
    Li X; Li H; Bi J; Chen Y; Jain S; Zhao Y
    Biochem Biophys Res Commun; 2012 Mar; 419(1):110-6. PubMed ID: 22330803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies.
    Mimeault M; Hauke R; Batra SK
    Clin Pharmacol Ther; 2007 Sep; 82(3):252-64. PubMed ID: 17671448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.